Primary Biliary Cholangitis is NOT a Contraindication to Lidocaine Infusion
Primary biliary cholangitis (PBC) does not represent a specific contraindication to lidocaine infusion. The only absolute contraindication to lidocaine is a known hypersensitivity to amide-type local anesthetics 1.
Key Evidence from Guidelines
The British Society of Gastroenterology/UK-PBC guidelines explicitly address drug safety in PBC, stating: "As with any liver disease, expert opinion is that caution must always be applied in therapeutics; however, there are no specific concerns regarding drug toxicity in PBC per se" 2. This clearly indicates that PBC itself does not contraindicate specific medications, including lidocaine.
Important Caveats Based on Disease Stage
While PBC is not a contraindication, the degree of hepatic impairment matters significantly:
Early-Stage PBC (Compensated Disease)
- Lidocaine can be used safely
- Standard dosing may be appropriate with monitoring
- No specific restrictions beyond normal precautions
Advanced PBC with Hepatic Dysfunction
The FDA labeling for lidocaine states: "Since amide-type local anesthetics are metabolized by the liver, lidocaine should be used with caution in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetic normally, are at a greater risk of developing toxic plasma concentrations" 1.
Practical Clinical Approach
For patients with PBC requiring lidocaine infusion:
- Assess hepatic function - Check bilirubin, synthetic function (INR, albumin), and presence of cirrhosis/decompensation
- Early PBC without cirrhosis: Use standard lidocaine dosing with routine monitoring
- Advanced PBC or cirrhosis: Reduce lidocaine dose commensurate with degree of hepatic impairment and monitor closely for signs of toxicity (restlessness, anxiety, tinnitus, dizziness, blurred vision, tremors) 1
- Decompensated cirrhosis: Consider dose reduction of 50% or more and maintain careful cardiovascular and neurological monitoring
Common Pitfall to Avoid
Do not confuse "use with caution in hepatic disease" with "contraindicated in hepatic disease." The diagnosis of PBC alone does not preclude lidocaine use - the critical factor is the degree of hepatic dysfunction, not the underlying diagnosis. Many patients with PBC on ursodeoxycholic acid have well-preserved hepatic function and can receive standard lidocaine dosing.